It is time round by social just and then the lightning round is over. Are you ready. Ski daddy the lightning round.Let's go to John in South Carolina. John, >> how you doing Jim. Couldn't be better.John, how about you. >> Doing fine down here in South Kakalaki. >> Yeah.Okay. What stock. >> BL.Yeah. Okay. Building stock.I can't I think the stock is well ahead of where it should be. Even though I like the company, the rest of the cohort is down. I would do some trimming of that stock.How about we go to Nichol ...

The award-winning work of Mary Brunkow, Fred Ramsdell and Sakaguchi Shimon identified cells fundamental to the development of medicines for cancer and autoimmunity https://t.co/5fM9y7bO7C ...

But Andrew Weissman, let me go uh first to you uh with your experience in the FBI uh and what we just listened to. Well, in many ways, it is the blueprint that was set in the Boston bombing case where you have this outreach to the public and the dissemination of information. It was striking to me that that was essentially the purpose of the press conference was to get that out there to the public so that anybody with information about um what he looks like um his t-shirt, his cap, his shoes, his backpack, a ...

Clinical Trial Overview - A clinical trial explored a "one-size-fits-all" vaccine's potential in preventing pancreatic cancer recurrence [1] - The trial included approximately 20 pancreatic cancer patients and 5 colorectal cancer patients, all having undergone standard treatments like chemotherapy and surgery [2] - Patients received six priming doses of an experimental vaccine [2] Vaccine Efficacy and Immune Response - The trial aimed to determine if the cancer vaccine could prevent recurrence and extend recurrence-free survival in patients who had standard treatments [3] - About 85% of individuals who received the cancer vaccine mounted the expected immune response [3] - Approximately two-thirds of the participants exhibited a robust immune response that was still detectable months after therapy, extending their cancer-free survival to about 29 months [3] Vaccine Mechanism and Significance - The cancer vaccine primes the immune system to recognize specific mutations present in cancer cells [5] - It introduces a snippet of a genetic mutation, triggering the immune system to identify and eliminate cells with that mutation [5] - This approach exploits the immune system's ability to kill cancer cells [5] Development Stage and Future Prospects - The trial was an early phase one trial with 25 participants [6] - Further success in phase two and phase three trials is necessary before potential FDA approval [6] - The vaccine targets a genetic mutation not specific to pancreatic or colorectal cancer, making it potentially usable in any cancer with that mutation [8][9]

Legal & Regulatory - The Delaware Supreme Court rejected expert testimony linking Zantac to cancer [1] - This is a major win for the drug makers involved [1]